Matches in Nanopublications for { ?s ?p "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP550972.RAbvTtxnMiCgtsJ0h2xAJN_hUaskO2JdWL9X8jcEf6CYU130_assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550972.RAbvTtxnMiCgtsJ0h2xAJN_hUaskO2JdWL9X8jcEf6CYU130_provenance.
- NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616138.RAUIwcdXRx6--dRF8uMD8gsy8tJbnDNfHAt_ofD1UYiAk130_provenance.
- assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872886.RAA3r5BOLRIuRNls_ez_nKFdZ-r6mIbwEzC-0Wet-izi0130_provenance.
- NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916343.RAeDzNzheeSq9Jt_w0ORdOEvOkKl6hu1d3Sen04sJUlNI130_provenance.
- NP872885.RAiNGHdgoXfSSh9PGTZBosXXtj5xTzC8rrvhTiEoSAg_I130_assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872885.RAiNGHdgoXfSSh9PGTZBosXXtj5xTzC8rrvhTiEoSAg_I130_provenance.
- NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842680.RApx9pZJX93jD0VTD4F6tbLiL9Yj2Qx4TRlnPuW1HlqNk130_provenance.
- NP916344.RAoqniwvuNcTBs1T8qv-oI1KE9SKV_FMXAkAj7cHfXNwE130_assertion description "[Biofluid studies identify about 15% of patients with FTLD due to a genetic mutation that is associated with the specific histopathologic features of TDP-43 or a tauopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916344.RAoqniwvuNcTBs1T8qv-oI1KE9SKV_FMXAkAj7cHfXNwE130_provenance.